- Not Fee assured
- Awaiting verification
I am a consultant cardiovascular Radiologist in NHS Greater Glasgow & Clyde and Honorary Clinical Associate Professor of Radiology, University of Glasgow. I have worked at Glasgow Royal Infirmary since 1997 with clinical and research interests in cardiovascular & thoracic radiology. I was involved with cardiac MRI while training in Aberdeen, with further experience gained in CMR techniques as visiting Fellow at Harvard University, Boston, USA. I have provided clinical CMR at Glasgow Royal Infirmary since 1998 and ECG gated cardiac CTA since 2004. My particular interests are in cardiac MRI, cardiac CTA, renovascular imaging, lower limb MRA techniques, carotid MRA and venous imaging. I am Level 3 accredited in both cardiac MRI and cardiac CT.
I am interested in all aspects of MRI contrast agents, including adverse events and risk management - I am the current Chair for Contrast Procurement in Scotland & Northern Ireland and this last year have updated the RCR Standards for Intravascular Contrast Administration to Adult Patients.
I am currently Treasurer of the British Society of Cardiovascular Imaging, closely involved as the society has become a professional organisation successfully negotiating the transition to formal charity status. I have been involved in promoting non-invasive cardiovascular imaging at all levels in the UK and internationally, current Chair of the Scottish Subcommittee of the BIR.
Areas of interest
Non-invasive cardiovascular imaging; cardiac CT; cardiac MRI; MRA (all body areas); chest radiology; stroke; renal disease; contrast media/agents
CT coronary angiography in patients with suspected angina due to coronary heart disease (SCOT-HEART): an open-label, parallel-group, multicentre trial. Newby D, et al Lancet March 2015.
The national evolution of cardiovascular CT practice: A UK NHS perspective. T K Mittal, E D Nicol, S P Harden, C A Roobottom, S P Padley, G Roditi, C R Peebles, A Taylor, M C Hamilton, G J Morgan-Hughes, R W Bury and British Society of Cardiovascular Imaging. International Journal of Cardiology 01/2013
Nephrogenic Systemic Fibrosis: Review of 370 Biopsy-confirmed Cases. Zou, Zhitong, Hong Lei Zhang, Giles H Roditi, Tim Leiner, Walter Kucharczyk, and Martin R Prince. JACC. Cardiovascular imaging 4, no. 11 (2011): doi:10.1016/j.jcmg.2011.08.013.
MR in Hypertension. Roditi G. Journal of Magnetic Resonance Imaging 2011;34(5):989-1006.
Peripheral arterial disease: The evolving role of non-invasive imaging. Owen AR, Roditi GH. Postgrad Med J 2011, Jan 27.
Risk factors for NSF: A literature review. Prince MR, Zhang HL, Roditi GH, Leiner T, Kucharczyk W. J Magn Reson Imaging 2009, Dec;30(6):1298-308.
Carotid artery imaging for secondary stroke prevention. Both imaging modality and rapid access to imaging are important. Wardlaw JM, Stevenson MD, Chappell F, Rothwell PM, Gillard J, Young G, et al. Stroke 2009, Sep 3.
Gadolinium-enhanced MR Imaging and Nephrogenic Systemic Fibrosis: Retrospective Study of a Renal Replacement Therapy Cohort. Collidge T A, Thomson P C, Mark P B, Traynor J P, Jardine A, Morris S T W, Simpson K & Roditi G. Radiology, 245(1):168-75, 2007.
Accurate, Practical and Cost-Effective Assessment of Carotid Stenosis in the UK. Wardlaw J M, Chappell F M, Stevenson M, De Nigris E, Thomas S, Gillard J, Berry E, Young G, Rothwell P, Roditi G, Gough M, Brennan A, Bamford J & Best J. Health technology Assessment NHS R&D HTA Programme. Health Technology Assessment, 10(30):iii-iv, ix-x, 1-182, 2006.
MRI Changes in Myocarditis - Evaluation with Spin Echo, Cine MR Angiography and Contrast Enhanced Spin Echo Imaging. Roditi G H, Hartnell G G, Cohen M C. Clinical Radiology 55(10):752-8, 2000.
Contrast-enhanced 3D MR Angiography using SENSE. Weiger M, Pruessmann KP, Kassner A, Roditi G H, Lawton T, Reid A & Boesiger P. Published in Journal of Magnetic Resonance Imaging 12(5):671-7, 2000.
Reference number 3090927
Affiliations / memberships